Benedicte F. Jordan

Avenue Mounier 73.08
Saint-lambert, WAL 1200, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications

A dual-modal 19F MRI/18F PET approach using sultone-derived chemical tags.

A dual-modal 19F MRI/18F PET approach using sultone-derived chemical tags.

Journal: The Analyst
Published: February 20, 2026

18 F-Fluorination of Nitroimidazolyl-Containing Sultone: A Direct Access to a Highly Hydrophilic Radiotracer for High-Performance Positron Emission Tomography Imaging of Hypoxia.

18 F-Fluorination of Nitroimidazolyl-Containing Sultone: A Direct Access to a Highly Hydrophilic Radiotracer for High-Performance Positron Emission Tomography Imaging of Hypoxia.

Journal: JACS Au
Published: June 25, 2024

The gut microbiome and cancer: from tumorigenesis to therapy.

The gut microbiome and cancer: from tumorigenesis to therapy.

Journal: Nature metabolism
Published: June 10, 2024

Luciferase transduction and selection protocol for reliable in vivo bioluminescent measurements in cancer research.

Luciferase transduction and selection protocol for reliable in vivo bioluminescent measurements in cancer research.

Journal: Heliyon
Published: April 09, 2024

Metabolic Profiling to Assess Response to Targeted and Immune Therapy in Melanoma.

Metabolic Profiling to Assess Response to Targeted and Immune Therapy in Melanoma.

Journal: International journal of molecular sciences
Published: December 21, 2023

PPARα-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinoma.

PPARα-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinoma.

Journal: Nature communications
Published: July 14, 2023

Hyperpolarized 13C-Pyruvate to Assess Response to Anti-PD1 Immune Checkpoint Inhibition in YUMMER 1.7 Melanoma Xenografts.

Hyperpolarized 13C-Pyruvate to Assess Response to Anti-PD1 Immune Checkpoint Inhibition in YUMMER 1.7 Melanoma Xenografts.

Journal: International journal of molecular sciences
Published: November 29, 2022

EPR Investigations to Study the Impact of Mito-Metformin on the Mitochondrial Function of Prostate Cancer Cells.

EPR Investigations to Study the Impact of Mito-Metformin on the Mitochondrial Function of Prostate Cancer Cells.

Journal: Molecules (Basel, Switzerland)
Published: August 24, 2022

Statins Alleviate Tumor Hypoxia in Prostate Cancer Models by Decreasing Oxygen Consumption: An Opportunity for Radiosensitization?

Statins Alleviate Tumor Hypoxia in Prostate Cancer Models by Decreasing Oxygen Consumption: An Opportunity for Radiosensitization?

Journal: Biomolecules
Published: August 02, 2022

Combined HP 13C Pyruvate and 13C-Glucose Fluxomic as a Potential Marker of Response to Targeted Therapies in YUMM1.7 Melanoma Xenografts.

Combined HP 13C Pyruvate and 13C-Glucose Fluxomic as a Potential Marker of Response to Targeted Therapies in YUMM1.7 Melanoma Xenografts.

Journal: Biomedicines
Published: February 21, 2022

Tumor Metabolism Is Affected by Obesity in Preclinical Models of Triple-Negative Breast Cancer.

Tumor Metabolism Is Affected by Obesity in Preclinical Models of Triple-Negative Breast Cancer.

Journal: Cancers
Published: December 17, 2021

Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer.

Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer.

Journal: Nature cancer
Published: November 05, 2021
Showing 1-12 of 74

Last Updated: 09/26/2026